Key result
RAS gene polymorphisms fail to predict pre-eclampsia alone, though combined clinical-genetic models show modest accuracy.
Why the study?
The relationship between renin-angiotensin system gene polymorphisms and vascular disease risk in pregnant women with pre-eclampsia was examined.
Are renin-angiotensin system gene polymorphisms (REN, AGT, AGTR1, AGTR2, BKR2) associated with an increased risk of pre-eclampsia in pregnant women?
Case-Control
Are renin-angiotensin system gene polymorphisms (REN, AGT, AGTR1, AGTR2, BKR2) associated with an increased risk of pre-eclampsia in pregnant women?
Individual renin-angiotensin system gene polymorphisms do not significantly differ in women with pre-eclampsia compared to normal pregnancies, except for the AGTR2 C/C genotype in those with chronic pyelonephritis, with a combined genetic and clinical model achieving 69% predictive accuracy.
Answers are grounded in this paper and cite their sources.
No support for these polymorphisms in preeclampsia risk assessment; leaves open contributions from other genetic factors.
In the present work the renin-angiotensin system gene polymorphisms REN (I9–83G > A), AGT (M235T), AGTR1 (1166A > C), AGTR2 (3123C > A), BKR2 (–58T > C) in pregnant women with preeclampsia, women with physiological pregnancy, healthy donors have been studied using allele-specific hybridization on the biochip. There were no statistically significant differences in genotypes distribution and allele frequencies of any genes between pre-eclampsia patients and women with normal pregnancy or donors (p > 0.05). However, it was shown that C/C genotype for the AGTR2 gene is a risk factor for preeclampsia in women with chronic pyelonephritis. In addition, accuracy of predicting the risk of pre-eclampsia based on the pyelonephritis availability and genotypes for genes AGTR1, AGTR2, BKR2 was 69 % using a logistic regression method
No takes yet. Share an insight, caveat, or question.
Glotov et al. (2012) conducted a case-control in Pre-eclampsia. Renin-angiotensin system gene polymorphisms (REN I9-83G>A, AGT M235T, AGTR1 1166A>C, AGTR2 3123C>A, BKR2 -58T>C) vs. Women with physiological pregnancy and healthy donors was evaluated on Genotype distribution and allele frequencies, and risk of pre-eclampsia (p=>0.05). RAS gene polymorphisms did not differ in pre-eclampsia overall, though combining pyelonephritis and AGTR1/AGTR2/BKR2 genotypes predicted pre-eclampsia with 69% accuracy.
Synapse has enriched 10 related papers. Consider them for comparative context: